Development and in vitro characterization of a novel pMDI diclofenac formulation as an inhalable anti-inflammatory therapy for cystic fibrosis

Modifying and Integrating in vitro and ex vivo Respiratory Models for Inhalation Drug Screening

(2020) Aylin Cidem et al.   Frontiers in Bioengineering and Biotechnology

Inflammation in cystic fibrosis: An update

(2018) Erica A. Roesch et al.   PEDIATRIC PULMONOLOGY

Pulmonary delivery of liposomal dry powder inhaler formulation for effective treatment of idiopathic pulmonary fibrosis

(2018) S. Chennakesavulu et al.   Asian Journal of Pharmaceutical Sciences

Critical Care of the Adult Patient With Cystic Fibrosis

(2018) Christopher S. King et al.   CHEST

Cystic Fibrosis: Emerging Understanding and Therapies

(2018) Michael M. Rey et al.   Annual Review of Medicine

Cystic fibrosis: current therapeutic targets and future approaches

(2017) Misbahuddin M. Rafeeq et al.   Journal of Translational Medicine

Cystic Fibrosis and Its Management Through Established and Emerging Therapies

(2016) David R. Spielberg et al.   Annual Review of Genomics and Human Genetics

Effect of diclofenac on SLC16A3/MCT4 by the Caco-2 cell line

(2016) Shotaro Sasaki et al.   Drug Metabolism and Pharmacokinetics

Carrier-free high-dose dry powder inhaler formulation of ibuprofen: Physicochemical characterization and in vitro aerodynamic performance

(2016) Ashkan K. Yazdi et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

The modified FACS calcein AM retention assay: A high throughput flow cytometer based method to measure cytotoxicity

(2016) M.A. Gillissen et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Primary Air–Liquid Interface Culture of Nasal Epithelium for Nasal Drug Delivery

(2016) Hui Xin Ong et al.   MOLECULAR PHARMACEUTICS

Inhaled antimicrobial therapy – Barriers to effective treatment

(2015) Jeffry Weers   ADVANCED DRUG DELIVERY REVIEWS

Junctional abnormalities in human airway epithelial cells expressing F508del CFTR

(2015) Samuel A. Molina et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Advances in NSAID Development: Evolution of Diclofenac Products Using Pharmaceutical Technology

(2015) Roy Altman et al.   DRUGS

Aspects of pulmonary drug delivery strategies for infections in cystic fibrosis – where do we stand?

(2015) Mareike Klinger-Strobel et al.   Expert Opinion on Drug Delivery

Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy

(2015) André M. Cantin et al.   Journal of Cystic Fibrosis

Biological Effects of Simvastatin Formulated as pMDI on Pulmonary Epithelial Cells

(2015) Alaa S. Tulbah et al.   PHARMACEUTICAL RESEARCH

Advances in Metered Dose Inhaler Technology: Formulation Development

(2014) Paul B. Myrdal et al.   AAPS PHARMSCITECH

Novel Simvastatin Inhalation Formulation and Characterisation

(2014) Alaa S. Tulbah et al.   AAPS PHARMSCITECH

Paracellular Transport through Healthy and Cystic Fibrosis Bronchial Epithelial Cell Lines – Do We Have a Proper Model?

(2014) Natalia Molenda et al.   PLoS One

Evaluation of an Abbreviated Impactor for Fine Particle Fraction (FPF) Determination of Metered Dose Inhalers (MDI)

(2013) Changning Guo et al.   AAPS PHARMSCITECH

Lipoxin A4-mediated KATP potassium channel activation results in cystic fibrosis airway epithelial repair

(2013) Paul J. Buchanan et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Ciprofloxacin Is Actively Transported across Bronchial Lung Epithelial Cells Using a Calu-3 Air Interface Cell Model

(2013) Hui Xin Ong et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The effect of ethanol on the formation and physico-chemical properties of particles generated from budesonide solution-based pressurized metered-dose inhalers

(2013) Bing Zhu et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Use of Non-Steroidal Anti-Inflammatory Drugs That Elevate Cardiovascular Risk: An Examination of Sales and Essential Medicines Lists in Low-, Middle-, and High-Income Countries

(2013) Patricia McGettigan et al.   PLOS MEDICINE

Diclofenac Salts, VIII. Effect of the Counterions on the Permeation through Porcine Membrane from Aqueous Saturated Solutions

(2012) Adamo Fini et al.   Pharmaceutics

Cardiovascular and Gastrointestinal Safety of NSAIDs: A Systematic Review of Meta-Analyses of Randomized Clinical Trials

(2011) F Salvo et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Diclofenac: an update on its mechanism of action and safety profile

(2010) Tong J. Gan   CURRENT MEDICAL RESEARCH AND OPINION

Nebulizer therapy in cystic fibrosis: An overview

(2009) Nicola Collins   JOURNAL OF THE ROYAL SOCIETY OF MEDICINE

Transport of Diclofenac by Breast Cancer Resistance Protein (ABCG2) and Stimulation of Multidrug Resistance Protein 2 (ABCC2)-Mediated Drug Transport by Diclofenac and Benzbromarone

(2008) J. S. Lagas et al.   DRUG METABOLISM AND DISPOSITION

The science of aerosol delivery in cystic fibrosis

(2008) David E. Geller   PEDIATRIC PULMONOLOGY